High Content Screening/Imaging market expected to reach $5.1 billion by 2029, with 8.4% CAGR.

From GlobeNewswire: 2025-04-22 14:56:00

In a new report by BCC Research, the High Content Screening/Imaging (HCS/I) market is projected to reach $5.1 billion by 2029, with a CAGR of 8.4%. Increasing R&D budgets driving innovation are fueling market growth. The report covers market drivers, trends, and key player shares, along with regional breakdowns.

HCS/I technology is being used in toxicity studies and neuroscience, with AI tools and automation advancing image analysis. Increasing R&D budgets are propelling innovation, while technological advances like AI integration and 3D cell models are enhancing drug discovery efficiency and accuracy.

The market is segmented by component, application, end user, and region, with the instruments segment projected to dominate in 2029. North America holds the largest market share, with key players including Agilent Technologies, Bio-Rad Laboratories, and Thermo Fisher Scientific.

Other related reports by BCC Research include Drug Discovery Technologies and Global Live Cell Imaging Market, focusing on advancements in medication development and real-time cell observation. For more information or to purchase a report, contact [email protected]. BCC Research provides unbiased market analysis to help businesses make informed decisions.



Read more at GlobeNewswire: High Content Screening and Imaging Market Set for 8.4% CAGR